Cited by 2,353HIV Research and TreatmentHIV/AIDS drug development and treatmentInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Open access

Heaton, R.K., Clifford, D.B., Franklin, D.R., Woods, S.P., Ake, C., Vaida, F., Ellis, R.J., Letendre, S.L., Marcotte, T.D., Atkinson, J.H., Rivera-Mindt, M., Vigil, O.R., Taylor, M.J., Collier, A.C., Marra, C.M., Gelman, B.B., McArthur, J.C., Morgello, S., Simpson, D.M., McCutchan, J.A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T.L., Wong, J., Grant, I., For the CHARTER Group·2010·Neurology

DOI 10.1212/wnl.0b013e318200d727PMC PMC2995535

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era of combination antiretroviral therapy (CART). METHODS: A total of 1,555 HIV-infected adults were recruited from 6 university clinics across the United States, with minimal exclusions. We used standardized neuromedical, psychiatric, and neuropsychological (NP) examinations, and recently published criteria for diagnosing HAND and classifying 3 levels of comorbidity (minimal to severe non-HIV risks for NP impairment). RESULTS: Fifty-two percent of the total sample had NP impairment, with higher rates in groups with greater comorbidity burden (40%, 59%, and 83%). Prevalence estimates for specific HAND diagnoses (excluding severely confounded cases) were 33% for asymptomatic neurocognitive impairment, 12% for mild neurocognitive disorder, and only 2% for HIV-associated dementia (HAD). Among participants with minimal comorbidities (n = 843), history of low nadir CD4 was a strong predictor of impairment, and the lowest impairment rate on CART occurred in the subset with suppressed plasma viral loads and nadir CD4 ≥200 cells/mm(3) (30% vs 47% in remaining subgroups). CONCLUSIONS: The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities. Future studies should clarify whether early disease events (e.g., profound CD4 decline) may trigger chronic CNS changes, and whether early CART prevents or reverses these changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318200d727

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Beck Depression Inventory–II
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Self-citation
Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
Letendre, S. L. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 831
Self-citation
The impact of HIV-associated neuropsychological impairment on everyday functioning
Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J. R., Moore, D. J., Bentley, H. A., McCutchan, J. A., REICKS, C., Grant, I., & THE HNRC GROUP (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704102130 · Cited by 726
Self-citation
The HNRC 500-Neuropsychology of Hiv infection at different disease stages
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700000230 · Cited by 636
Self-citation
HIV and antiretroviral therapy in the brain: neuronal injury and repair
Ellis, R. J., Langford, D., & Masliah, E. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn2040 · Cited by 533
Self-citation
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
Cartier, L., Hartley, O., Dubois‐Dauphin, M., & Krause, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 520
Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment
Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M. F., Comandini, U. V., Vlassi, C., Giulianelli, M., Galgani, S., Antinori, A., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318042e1ee · Cited by 323
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A. E., Heaton, R. K., Wallace, M. R., ABRAMSON, I. S., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410420503 · Cited by 318
Self-citation
Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV
Woods, S. P., Rippeth, J. D., Frol, A. B., Levy, J. K., Ryan, E., Soukup, V. M., Hinkin, C. H., Lazzaretto, D., Cherner, M., Marcotte, T. D., et al. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490509565 · Cited by 311
Self-citation

Show all 33 references

Sorted by citations

Items 201–300 of 1,002

Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production
Chen, X., Hui, L., Geiger, N. H., Haughey, N. J., & Geiger, J. D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.015 · Cited by 75
Central Nervous System Penetration of Antiretroviral Drugs: Pharmacokinetic, Pharmacodynamic and Pharmacogenomic Considerations
Decloedt, E. H., Rosenkranz, B., Maartens, G., & Joska, J. A. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0257-3 · Cited by 75
Role of HIV in Amyloid Metabolism
Ortega, M., & Ances, B. M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9546-0 · Cited by 78
A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review
Bloch, M. T., Kamminga, J., Jayewardene, A. F., Bailey, M., Carberry, A. E., Vincent, T., Quan, D., Maruff, P. T., Brew, B. J., & Cysique, L. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw399 · Cited by 75
Aging with HIV in the ART era
Kaplan‐Lewis, E., Aberg, J. A., & Lee, M.-K. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.04.002 · Cited by 80
Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders
Roşca, E. C., Albarqouni, L., & Simu, M. A. (2019) · Neuropsychology Review · doi:10.1007/s11065-019-09412-9 · Cited by 76
Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter
Kallianpur, K. J., Shikuma, C. M., Kirk, G. R., Shiramizu, B. T., Valcour, V., Chow, D. C., Souza, S. A., Nakamoto, B. K., & Sailasuta, N. (2013) · Neurology · doi:10.1212/wnl.0b013e318291903f · Cited by 73
HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research
Cysique, L. A., Heaton, R. K., Kamminga, J., Lane, T. A., Gates, T. M., Moore, D. M., Hubner, E., Carr, A. D., & Brew, B. J. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0242-x · Cited by 73
Self-citation
Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV‐infected older adults
Wilson, T. W., Heinrichs‐Graham, E., Becker, K. M., Aloi, J. M., Robertson, K. R., Sandkovsky, U., White, M. L., O’Neill, J., Knott, N. L., Fox, H. S., et al. (2014) · Human Brain Mapping · doi:10.1002/hbm.22674 · Cited by 73
Comparative analysis of human microglial models for studies of HIV replication and pathogenesis
Mohammad, A., Hammonds, J. E., Pujato, M. A., Mayhew, C. N., Roskin, K. M., & Spearman, P. W. (2020) · Retrovirology · doi:10.1186/s12977-020-00544-y · Cited by 78
Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease
The HNRP Group, Fazeli, P. L., Marquine, M. J., Dufour, C. A., Henry, B. L., Montoya, J. L., Gouaux, B. D., Moore, R. C., Letendre, S. L., Woods, S. P., et al. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1024-z · Cited by 81
Self-citation
Antiretroviral Monocyte Efficacy Score Linked to Cognitive Impairment in Hiv
Shikuma, C. M., Nakamoto, B. K., Shiramizu, B. T., Liang, C.-Y., DeGruttola, V. G., Bennett, K. K., Paul, R. H., Kallianpur, K. J., Chow, D. C., Gavegnano, C., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2411 · Cited by 72
Characterization of Platelet–Monocyte Complexes in HIV-1–Infected Individuals: Possible Role in HIV-Associated Neuroinflammation
Singh, M. V., Davidson, D. C., Jackson, J. W., Singh, V. B., Silva, J., Ramirez, S. H., & Maggirwar, S. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302318 · Cited by 72
Younger Onset Dementia
Sansoni, J., Duncan, C., Grootemaat, P. E., Capell, J. T., Samsa, P., & Westera, A. (2016) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515619481 · Cited by 79
Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History
Devlin, K. N., Gongvatana, A., Clark, U. S., Chasman, J. D., Westbrook, M. L., Tashima, K. T., NAVIA, B. A., & Cohen, R. A. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617711001408 · Cited by 74
HIV and viral protein effects on the blood brain barrier
McRae, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1143543 · Cited by 74
Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients
Dickens, A. M., Anthony, D. C., Deutsch, R., Mielke, M. M., Claridge, T. D. W., Grant, I., Franklin, D. R., Cookson, D. R., Marcotte, T. D., Letendre, S. L., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000580 · Cited by 71
Self-citation
Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy
Rahimy, E., Li, F., Hagberg, L., Fuchs, D., Robertson, K., Meyerhoff, D. J., Zetterberg, H., Price, R. W., Gisslén, M., & Spudich, S. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix013 · Cited by 71
Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
Dahl, V., Lee, E., Peterson, J. J., Spudich, S., Leppla, I. E., Sinclair, E., Fuchs, D., Palmer, S., & Price, R. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir667 · Cited by 70
The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population
Cody, S. L., & Vance, D. E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.011 · Cited by 70
HIV-1 Tat-Induced Microgliosis and Synaptic Damage via Interactions between Peripheral and Central Myeloid Cells
Lu, S., Tremblay, M., King, I. L., Qi, J., Reynolds, H. M., Marker, D. F., Varrone, J. J., Majewska, A. K., Dewhurst, S., & Gelbard, H. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023915 · Cited by 70
Dopamine Increases CD14+CD16+ Monocyte Migration and Adhesion in the Context of Substance Abuse and HIV Neuropathogenesis
Coley, J. S., Calderon, T. M., Gaskill, P. J., Eugenin, E. A., & Berman, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117450 · Cited by 70
Feasibility and Acceptability of Ecological Momentary Assessment of Daily Functioning Among Older Adults with HIV
Moore, R. C., Kaufmann, C. N., Rooney, A. S., Moore, D. J., Eyler, L. T., Granholm, E. L., Woods, S. P., Swendsen, J. D., Heaton, R. K., Scott, J. C., et al. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.11.019 · Cited by 72
Self-citation
Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages
Gong, Y., Chowdhury, P., Nagesh, P. K. B., Rahman, M. A., Zhi, K., Yallapu, M. M., & Kumar, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-60684-1 · Cited by 69
Low Rates of Neurocognitive Impairment Are Observed in Neuro-Asymptomatic HIV-Infected Subjects on Effective Antiretroviral Therapy
Garvey, L. J., Surendrakumar, V., & Winston, A. (2011) · HIV Clinical Trials · doi:10.1310/hct1206-333 · Cited by 69
Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer
Fields, J. A., Dumaop, W., Rockenstein, E. M., Mante, M., Spencer, B. J., Grant, I., Ellis, R. J., Letendre, S. L., Patrick, C., Adame, A., et al. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-012-0145-7 · Cited by 69
Self-citation
Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders
Davidson, D. C., Hirschman, M. P., Sun, A., Singh, M. V., Kasischke, K. A., & Maggirwar, S. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051793 · Cited by 71
Platelet-derived growth factor (PDGF)-BB-mediated induction of monocyte chemoattractant protein 1 in human astrocytes: implications for HIV-associated neuroinflammation
Bethel-Brown, C. S., Yao, H., Hu, G., & Buch, S. J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-262 · Cited by 69
Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models
Soontornniyomkij, V., Kesby, J. P., Morgan, E. E., Bischoff‐Grethe, A., Minassian, A., Brown, G. G., & Grant, I. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9699-0 · Cited by 69
Self-citation
Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation
Raghavan, A., Rimmelin, D., Fitch, K. V., & Zanni, M. V. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0366-8 · Cited by 69
Predictors of symptomatic HIV ‐associated neurocognitive disorders in universal health care
McCombe, J. A., Vivithanaporn, P., Gill, M. J., & Power, C. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2012.01043.x · Cited by 68
Identifying Risk Factors for HIV-Associated Neurocognitive Disorders Using the International HIV Dementia Scale
Cross, S. L., Önen, N. F., Gase, A., Overton, E. T., & Ances, B. M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9505-1 · Cited by 68
Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury
Yuan, N. Y., & Kaul, M. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09868-9 · Cited by 68
Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects
Ho, E. L., Ronquillo, R., Altmeppen, H. C., Spudich, S., Price, R. W., & Sinclair, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066188 · Cited by 68
Evolving clinical phenotypes in HIV-associated neurocognitive disorders
Sacktor, N. C., & Robertson, K. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000102 · Cited by 67
Functional Brain Abnormalities During Finger-Tapping in HIV-Infected Older Adults: A Magnetoencephalography Study
Wilson, T. W., Heinrichs‐Graham, E., Robertson, K. R., Sandkovsky, U., O’Neill, J., Knott, N. L., Fox, H. S., & Swindells, S. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9477-1 · Cited by 67
Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders
Gill, A. J., Kovacsics, C. E., Cross, S. A., Vance, P. J., Kolson, L. L., Jordan‐Sciutto, K. L., Gelman, B. B., & Kolson, D. L. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72279 · Cited by 67
Self-citation
HIV, dementia and antiretroviral drugs: 30 years of an epidemic
Manji, H., Jäger, H. R., & Winston, A. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304022 · Cited by 69
Didehydro-Cortistatin A Inhibits HIV-1 Tat Mediated Neuroinflammation and Prevents Potentiation of Cocaine Reward in Tat Transgenic Mice
Mediouni, S., Jablonski, J. A., Paris, J. J., Clementz, M. A., Thenin-Houssier, S., McLaughlin, J. P., & Valente, S. T. (2015) · Current HIV Research · doi:10.2174/1570162x13666150121111548 · Cited by 67
ASHP Guidelines on Pharmacist Involvement in HIV Care
Schafer, J. J., Gill, T. K., Sherman, E. M., McNicholl, I. R., & Hawkins, B. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150623 · Cited by 69
Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV
Watson, C. W., Paolillo, E. W., Morgan, E. E., Umlauf, A., Sundermann, E. E., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Heaton, R. K., & Grant, I. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002211 · Cited by 66
Self-citation
Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders
Irollo, E., Luchetta, J., Ho, C.-T., Nash, B., & Meucci, O. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03785-y · Cited by 66
Sex Differences in Neuropsychological Performance as an Effect of Human Immunodeficiency Virus Infection
Hestad, K. A., Menon, J. A., Ngoma, M. S., Franklin, D. R., Imasiku, M. L., Kalima, K., & Heaton, R. K. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e31824cc225 · Cited by 66
Self-citation
Is It Time to Rethink How Neuropsychological Tests Are Used to Diagnose Mild Forms of HIV-Associated Neurocognitive Disorders? Impact of False-Positive Rates on Prevalence and Power
Meyer, A.-C. L., Boscardin, W. J., Kwasa, J. K., & Price, R. W. (2013) · Neuroepidemiology · doi:10.1159/000354629 · Cited by 66
MicroRNAs in the Brain: It's Regulatory Role in Neuroinflammation
Thounaojam, M. C., Kaushik, D. K., & Basu, A. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8400-3 · Cited by 66
Autophagy in Dementias
Kragh, C. L., Ubhi, K. K., Wyss‐Coray, T., & Masliah, E. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00545.x · Cited by 66
Antiretroviral drug treatment of CNS HIV-1 infection
Yilmaz, A., Price, R. W., & Gisslén, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr492 · Cited by 66
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo- l -norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders
Nedelcovych, M. T., Tenora, L., Kim, B.-H., Kelschenbach, J., Chao, W., Hadas, E., Jančařík, A., Prchalová, E., Zimmermann, S. C., Dash, R. P., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00966 · Cited by 66
Can high central nervous system penetrating antiretroviral regimens protect against the onset of HIV-associated neurocognitive disorders?
Vassallo, M., Durant, J., Biscay, V., Lebrun‐Frénay, C., Dunais, B., Laffon, M., Harvey-Langton, A., Cottalorda, J., Ticchioni, M., Carsenti, H., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000096 · Cited by 70
Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies
McArthur, J. C., & Johnson, T. P. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000807 · Cited by 66
Self-citation
Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids
Gumbs, S. B. H., Berdenis van Berlekom, A., Kübler, R., Schipper, P. J., Gharu, L., Boks, M. P., Ormel, P. R., Wensing, A. M. J., de Witte, L. D., & Nijhuis, M. (2022) · Viruses · doi:10.3390/v14040829 · Cited by 65
HIV Associated Neurocognitive Disorders (HAND) in Malawian Adults and Effect on Adherence to Combination Anti-Retroviral Therapy: A Cross Sectional Study
Kelly, C., van Oosterhout, J. J., Ngwalo, C., Stewart, R. C., Benjamin, L. A., Robertson, K. R., Khoo, S., Allain, T. J., & Solomon, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098962 · Cited by 65
Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy
Anderson, A. M. L., Harezlak, J., Bharti, A., Mi, D., Taylor, M. J., Daar, E. S., Schifitto, G., Zhong, J., Alger, J. R., Brown, M. S., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000532 · Cited by 65
Self-citation
Determinants of reduced cognitive performance in HIV-1-infected middle-aged men on combination antiretroviral therapy
Schouten, J., Su, T., Wit, F. W. N. M., Kootstra, N. A., Caan, M. W. A., Geurtsen, G. J., Schmand, B. A., Stolte, I. G., Prins, M., Majoie, C. B. L. M., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001017 · Cited by 65
Household Everyday Functioning in the Internet Age: Online Shopping and Banking Skills Are Affected in HIV−Associated Neurocognitive Disorders
Woods, S. P., Iudicello, J. E., Morgan, E. E., Verduzco, M., Smith, T. V., & Cushman, C. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717000431 · Cited by 65
Self-citation
Minimal Cognitive Impairment in UK HIV-Positive Men Who Have Sex With Men
McDonnell, J., Haddow, L. J., Daskalopoulou, M., Lampe, F. C., Speakman, A., Gilson, R. J. C., Phillips, A. N., Sherr, L., Wayal, S., Harrison, J., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000273 · Cited by 64
Cognitive Neurorehabilitation of HIV-associated Neurocognitive Disorders: A Qualitative Review and Call to Action
Weber, E., Blackstone, K., & Woods, S. P. (2013) · Neuropsychology Review · doi:10.1007/s11065-013-9225-6 · Cited by 64
Self-citation
Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study
Carvalhal, A., Gill, M. J., Letendre, S. L., Rachlis, A., Bekele, T., Raboud, J., Burchell, A. N., & Rourke, S. B. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0404-5 · Cited by 64
Self-citation
Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity
Gott, C., Gates, T. M., Dermody, N., Brew, B. J., & Cysique, L. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171887 · Cited by 64
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy
Valero, I., Ellis, R. J., Heaton, R. K., Deutsch, R., Franklin, D. R., Clifford, D. B., Collier, A. C., Gelman, B. B., Marra, C. M., McCutchan, J. A., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002074 · Cited by 64
Self-citation
The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders
Marker, D. F., Tremblay, M., Puccini, J. M., Barbieri, J., Marker, M. A. G., Loweth, C. J., Muly, E. C., Lu, S., Goodfellow, V. S., Dewhurst, S., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0598-13.2013 · Cited by 63
The Alzheimer’s disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons
Overton, E. T., Azad, T. D., Parker, N., Shaw, D. D., Frain, J., Spitz, T., Westerhaus, E. T., Paul, R. H., Clifford, D. B., & Ances, B. M. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-012-0147-5 · Cited by 63
Self-citation
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders
Morgan, E. E., Woods, S. P., Letendre, S. L., Franklin, D. R., Bloss, C. S., Goate, A., Heaton, R. K., Collier, A. C., Marra, C. M., Gelman, B. B., et al. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0152-3 · Cited by 63
Self-citation
Sleep, Fatigue, and Problems With Cognitive Function in Adults Living With HIV
Byun, E., Gay, C., & Lee, K. A. (2015) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2015.10.002 · Cited by 63
T cells establish and maintain CNS viral infection in HIV-infected humanized mice
Honeycutt, J. B., Liao, B., Nixon, C. C., Cleary, R. A., Thayer, W. O., Birath, S., Swanson, M. D., Sheridan, P. A., Zakharova, O. I., Prince, F., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98968 · Cited by 63
HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders
Cotto, B., Natarajanseenivasan, K., & Langford, D. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101616 · Cited by 65
Disrupted Brain Networks in the Aging HIV+ Population
Jahanshad, N., Valcour, V., Nir, T. M., Omid Kohannim, A., Busovaca, E., Nicolas, K., & Thompson, P. M. (2012) · Brain Connectivity · doi:10.1089/brain.2012.0105-rev · Cited by 62
Socioeconomic Status and Neuropsychological Functioning: Associations in an Ethnically Diverse HIV+ Cohort
Arentoft, A., Byrd, D., Monzones, J., Coulehan, K., Fuentes, A., Rosario, A., Miranda, C., Morgello, S., & Rivera Mindt, M. (2015) · The Clinical Neuropsychologist · doi:10.1080/13854046.2015.1029974 · Cited by 62
Self-citation
Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport
Sun, W., Quizon, P. M., Yuan, Y., Strauss, M. J., McCain, R. S., Zhan, C., & Zhu, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-39872-1 · Cited by 63
Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting
Rawson, T. M., Muir, D. A., Mackie, N., Garvey, L. J., Everitt, A. D., & Winston, A. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.04.007 · Cited by 62
A Concise Panel of Biomarkers Identifies Neurocognitive Functioning Changes in HIV-Infected Individuals
for the CHARTER Group, Marcotte, T. D., Deutsch, R., Michael, B. D., Franklin, D. R., Cookson, D. R., Bharti, A., Grant, I., & Letendre, S. L. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9504-2 · Cited by 62
Self-citation
Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis
Calderon, T. M., Williams, D. W., Lopez, L., Eugenín, E. A., Cheney, L., Gaskill, P. J., Veenstra, M., Anastos, K., Morgello, S., & Berman, J. W. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-017-9726-9 · Cited by 62
Self-citation
Very Early Initiation of Antiretroviral Therapy During Acute HIV Infection Is Associated With Normalized Levels of Immune Activation Markers in Cerebrospinal Fluid but Not in Plasma
Hellmuth, J. M., Slike, B. M., Sacdalan, C., Best, J., Kroon, E. D. M. B., Phanuphak, N., Fletcher, J. L. K., Prueksakaew, P., Jagodzinski, L. L., Valcour, V., et al. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz030 · Cited by 62
Cumulative multiple early life hits- a potent threat leading to neurological disorders
Sarkar, T., Patro, N., & Patro, I. K. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.02.005 · Cited by 64
Elevated rates of mild cognitive impairment in HIV disease
Sheppard, D. P., Iudicello, J. E., Bondi, M. W., Doyle, K. L., Morgan, E. E., Massman, P. J., Gilbert, P. E., & Woods, S. P. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0366-7 · Cited by 64
Self-citation
HIV infection of non-classical cells in the brain
Wahl, A. R., & Al‐Harthi, L. (2023) · Retrovirology · doi:10.1186/s12977-023-00616-9 · Cited by 63
Age, stress, and isolation in older adults living with HIV
Webel, A. R., Longenecker, C. T., Gripshover, B., Hanson, J. E., Schmotzer, B. J., & Salata, R. A. (2013) · AIDS Care · doi:10.1080/09540121.2013.845288 · Cited by 65
Evaluating Sleep and Cognition in HIV
Gamaldo, C. E., Gamaldo, A. A., Creighton, J. A., Salas, R. M. E., Selnes, O. A., David, P. M., Mbeo, G., Parker, B. S., Brown, A. M., McArthur, J. C., et al. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829d63ab · Cited by 61
Self-citation
A lipid storage–like disorder contributes to cognitive decline in HIV-infected subjects
Bandaru, V. V. R., Mielke, M. M., Sacktor, N., McArthur, J. C., Grant, I., Letendre, S., Chang, L., Wojna, V., Pardo, C., Calabresi, P., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a9565e · Cited by 61
Self-citation
Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence
Gill, A. J., & Kolson, D. L. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0210-3 · Cited by 61
Human Immunodeficiency Virus Type 1 (HIV-1) Transactivator of Transcription through Its Intact Core and Cysteine-Rich Domains Inhibits Wnt/β-Catenin Signaling in Astrocytes: Relevance to HIV Neuropathogenesis
Henderson, L. J., Sharma, A. K., Monaco, M. C., Major, E. O., & Al‐Harthi, L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3145-12.2012 · Cited by 60
Mechanisms of HIV-1 Tat Neurotoxicity via CDK5 Translocation and Hyper-Activation: Role in HIV-Associated Neurocognitive Disorders
Fields, J. A., Dumaop, W., Crews, L. A., Adame, A., Spencer, B. J., Metcalf, J., He, J. J., Rockenstein, E. M., & Masliah, E. (2015) · Current HIV Research · doi:10.2174/1570162x13666150311164201 · Cited by 61
Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era
Guha, A., Brier, M. R., Ortega, M., Westerhaus, E. T., Nelson, B., & Ances, B. M. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001111 · Cited by 60
A pilot study on the effects of probiotic supplementation on neuropsychological performance and micro RNA ‐29a‐c levels in antiretroviral‐treated HIV ‐1‐infected patients
Ceccarelli, G., Fratino, M., Selvaggi, C., Giustini, N., Serafino, S., Schietroma, I., Scheri, G. C., Pavone, P., Passavanti, G., Fegatelli, D. A., et al. (2017) · Brain and Behavior · doi:10.1002/brb3.756 · Cited by 60
Aberrant oscillatory dynamics during somatosensory processing in HIV-infected adults
Spooner, R. K., Wiesman, A. I., Mills, M. S., O’Neill, J., Robertson, K. R., Fox, H. S., Swindells, S., & Wilson, T. W. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.07.009 · Cited by 61
Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders
Rosenthal, J. F., & Tyor, W. R. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00735-0 · Cited by 60
The role of oxidative stress in HIV-associated neurocognitive disorders
Buckley, S., Byrnes, S. J., Cochrane, C. R., Roche, M., Estes, J. D., Selemidis, S., Angelovich, T. A., & Churchill, M. J. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100235 · Cited by 61
Identification, Quantification, and Characterization of HIV-1 Reservoirs in the Human Brain
Donoso, M., Damico, D. C. S., Valdebenito, S., Hernandez, C. A., Prideaux, B., & Eugenín, E. A. (2022) · Cells · doi:10.3390/cells11152379 · Cited by 59
Leucine-Rich Repeat Kinase 2 Modulates Neuroinflammation and Neurotoxicity in Models of Human Immunodeficiency Virus 1-Associated Neurocognitive Disorders
Puccini, J. M., Marker, D. F., Fitzgerald, T., Barbieri, J., Kim, C. S., Miller‐Rhodes, P., Lu, S., Dewhurst, S., & Gelbard, H. A. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0650-14.2015 · Cited by 59
Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIV-infected patients on stable treatmentpatients on stable treatment
Hua, X., Boyle, C. P., Harezlak, J., Tate, D. F., Yiannoutsos, C. T., Cohen, R. A., Schifitto, G., Gongvatana, A., Zhong, J., Zhu, T., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.07.009 · Cited by 59
Self-citation
Human Immunodeficiency Virus Infection Heightens Concurrent Risk of Functional Dependence in Persons With Long-Term Methamphetamine Use
Blackstone, K., Iudicello, J. E., Morgan, E. E., Weber, E., Moore, D. J., Franklin, D. R., Ellis, R. J., Grant, I., & Woods, S. P. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318293653d · Cited by 59
Self-citation
Aberrant Neuronal Dynamics during Working Memory Operations in the Aging HIV-Infected Brain
Wilson, T. W., Proskovec, A. L., Heinrichs‐Graham, E., O’Neill, J., Robertson, K. R., Fox, H. S., & Swindells, S. (2017) · Scientific Reports · doi:10.1038/srep41568 · Cited by 60
Astrocyte senescence and metabolic changes in response to HIV antiretroviral therapy drugs
Cohen, J., D’Agostino, L., Wilson, J., Tuzer, F., & Torres, C. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00281 · Cited by 58
DHEA and Cognition in HIV-Positive Patients with Non-Major Depression
Bradley, M. V., McElhiney, M. C., & Rabkin, J. G. (2012) · Psychosomatics · doi:10.1016/j.psym.2011.08.005 · Cited by 58
HIV-associated neurocognitive disorders: Antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes
Cross, H., Combrinck, M. I., & Joska, J. A. (2013) · South African Medical Journal · doi:10.7196/samj.6677 · Cited by 58
HIV-associated neurocognitive disorders (HAND) in a South Asian population - contextual application of the 2007 criteria
Chan, L. G., Kandiah, N., & Chua, A. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000662 · Cited by 58
Cerebrospinal fluid miRNA profile in HIV‐encephalitis
Pacifici, M., Delbue, S., Ferrante, P., Jeansonne, D. P., Kadri, F., Nelson, S., Velasco‐Gonzalez, C., Zabaleta, J., & Peruzzi, F. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24254 · Cited by 58
Morbidity in older HIV-infected patients: impact of long-term antiretroviral use.
Guaraldi, G., Prakash, M., Moecklinghoff, C., & Stellbrink, H. (2014) · PubMed · Cited by 58
Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy
Guha, D., Mukerji, S. S., Chettimada, S., Misra, V., Lorenz, D. R., Morgello, S., & Gabuzda, D. H. (2018) · AIDS · doi:10.1097/qad.0000000000002121 · Cited by 58
Self-citation
The Effects of Opioids on HIV Neuropathogenesis
Murphy, A., Barbaro, J. M., Martínez-Aguado, P., Chilunda, V., Jaureguiberry-Bravo, M., & Berman, J. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02445 · Cited by 58

Authors: Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T. L., Wong, J., Grant, I., & For the CHARTER Group
Affiliations: University of California San Diego (US)
From the University of California (R.K.H., D.R.F., S.P.W., C.A., F.V., R.J.E., S.L.L., T.D.M., J.H.A., O.R.V., M.J.T., J.A.M., I.A., A.G., C.F.-N., T.L.J., I.G.), San Diego; University of California (J.W.), San Francisco; Washington University (D.B.C.), St. Louis, MO; Mount Sinai School of Medicine (M.R.-M., S.M., D.M.S.), New York, NY; University of Washington (A.C.C., C.M.M.), Seattle; University of Texas Medical Branch (B.B.G.), Galveston; and Johns Hopkins University (J.C.M.), Baltimore, MD.
ORCID: Heaton, R.K.
Clifford, D.B.
Franklin, D.R.
Woods, S.P.
Vaida, F.
Ellis, R.J.
Letendre, S.L.
Marcotte, T.D.
Taylor, M.J.
Collier, A.C.
Marra, C.M.
McArthur, J.C.
Morgello, S.
Simpson, D.M.
McCutchan, J.A.
Jernigan, T.L.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-12-07
Volume: 75
Issue: 23
Pages: 2087-2096
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0b013e318200d727
PMC: PMC2995535
OpenAlex: W2137321682
Cited by: 2,353
References: 33
Citations by year: 2026: 92 · 2025: 93 · 2024: 119 · 2023: 131 · 2022: 127 · 2021: 182 · 2020: 172 · 2019: 225 · 2018: 153 · 2017: 202 · 2016: 181 · 2015: 172 · 2014: 165 · 2013: 152 · 2012: 115
FWCI: 38.09
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Neurology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Fordham Research Commons (Fordham University) (submittedVersion)
Funders: National Institutes of Health (5u01ai069495-05, n01mh22005-16-0-1, 5r01ag024506-03, 5r01ns036524-10, N01 MH22005, MH22005)
Centers for Disease Control and Prevention (U2G PS00623)
U.S. Public Health Service (R213857-53187, NIMH-22005)
National Institute on Alcohol Abuse and Alcoholism (R01 AA13419, R01AA013419, R32AA17321)
National Institute on Aging (R01AG015301, U01‐AG10483, R01AG031224, R01-AG024506, R01 AG-15301, U01AG010483, R01AG022381, U19AG010483)
National Heart, Lung, and Blood Institute (R01HL084229, R01 HL95089, R01 HL84229, R01HL095089)
National Institute of Mental Health (U01MH083507, U01-MH83506, R21-MH85610, R01MH067831, U01MH083506, R01-MH73419, N01 MH-22005, R01 MH73433, R01MH079881, N01 MH22005-08, R01 MH-60720, R01 MH78748, R01MH058076, R21MH78728, MH 22005, N01MH022005, R01MH064907, K23MH079718, R01MH081861, MH058076, R01MH085608, R01 MH78737, R01MH64907, R01MH083552, R01MH073419, R24-MH-59724, U13 MH81676, R32 MH77487, R01MH079886, R24MH059724, R21MH078728, U01MH083501, R01MH38552, R01MH078737, R21MH085610, R01 MH81861, R01 MH83552, R01 MH79752, R01MH078748, R01MH073433, R01MH079752, R01MH060720, P30MH62512, R01MH061146, MH085608-01, MH083506-02, R01 MH61146, R01 MH79881, R01 MH075673, R21MH083573, R01MH084796, MH083552-02, P30MH062512, U13MH081676, R01 MH58076)
National Institute on Drug Abuse (P50DA026306, R01 DA21115, RC2DA029475, DA026306-01, P01DA012065, P50DA26306, RC2-DA29475, P01-DA12065, DA012065-10, DA026146, P01DA026146, R03DA022137, R01DA021115)
National Institute of Allergy and Infectious Diseases (AI 27757, R01-AI47033, AI-069434, AI069918, UO1AI69495, U01 AI74521, U01AI074521, R01AI034235, U01AI069432, R01AI047033, 00-AI-0005, U01 AI69432, R01AI087145, P01AI057005, AI069438, AI068543, 1R01 NS/AI34235, P30AI027757, U01AI069918)
National Institute of Neurological Disorders and Stroke (R01 NS44807, R21NS069355, R01NS049465, UO1 NS32228, R01NS044807, R01NS49465, RC1NS068904, R01-NS-41198, R01NS041198, R01-NS36524, R01NS051132, U01NS032228)
National Center for Research Resources (U24RR021992, U24RR021382, K30RR22681, K30RR022681, U24 RR21382, U24RR019701)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: HIV-associated neurocognitive disorders, HIV-associated dementia, highly active antiretroviral therapy, CD4 nadir, viral suppression, comorbidities, asymptomatic neurocognitive impairment, mild neurocognitive disorder, HIV infection
MeSH terms: Activities of Daily Living, Adult, Algorithms, Cognition Disorders, Disability Evaluation, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Neurologic Examination, Neuropsychological Tests, Psychiatric Status Rating Scales, Retrospective Studies, Models, Statistical, HIV Infections, Cross-Over Studies, Observation, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks